Gulf Scientific Corporation announces strategic partnership with GeneMind Biosciences to advance molecular diagnostics and pioneer non-invasive prenatal testing (NIPT)
Gulf Scientific Corporation (GSC), a leading provider of scientific and laboratory solutions, is pleased to announce a strategic partnership with GeneMind Biosciences, a pioneering developer of DNA sequencing systems. This alliance marks a significant milestone in our ongoing commitment to delivering innovative healthcare solutions and advancing molecular diagnostics.
Founded with a focus on research and development, GeneMind Biosciences is a key player in the development of high-performance DNA sequencers – core instruments of modern molecular diagnostics. The company is committed to building a comprehensive precision medical ecosystem by collaborating with genetic testing service providers and medical institutions worldwide.
This partnership with GSC represents a shared vision to enhance diagnostic capabilities, support cutting-edge scientific research, and ultimately improve patient outcomes. By combining GSC's extensive network and expertise with GeneMind's innovative sequencing technology, we aim to drive forward the future of healthcare through advanced molecular diagnostics, including non-invasive prenatal testing (NIPT).
GSC is proud to represent GeneMind Biosciences in the UAE, Kuwait, Oman, Bahrain, and Qatar, bringing their groundbreaking NIPT technology to healthcare providers and patients across these markets.
GeneMind's cutting-edge NIPT technology allows for early and accurate detection of fetal chromosomal abnormalities, reducing the risk of miscarriage and improving pregnancy outcomes. This technology has the potential to revolutionize prenatal care and improve the lives of expectant mothers.
'We are excited to collaborate with GeneMind Biosciences, whose innovative DNA sequencing solutions align perfectly with our mission to empower healthcare providers to achieve their scientific objectives by providing innovative and reliable solutions, application support, and comprehensive after-sales services,' stated Manaf Afyouni, Managing Director of Gulf Scientific Corporation. 'Our partnership will enable us to bring cutting-edge NIPT technology to the region, enhancing prenatal care and improving patient outcomes.'
As part of this strategic partnership, GSC will be providing comprehensive support and services to healthcare professionals within the region. This collaboration will also facilitate the development of new research initiatives and projects focused on advancing molecular diagnostics and NIPT.
We look forward to sharing updates on the groundbreaking initiatives and projects that will result from this strategic partnership.
For more information about Gulf Scientific Corporation and our solutions, including GeneMind's NIPT technology, please visit https://gulf-scientific.com/partners/genemind/ Source: AETOSWire
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
2 days ago
- Zawya
Gulf Scientific Corporation announces strategic partnership with GeneMind Biosciences
DUBAI, United Arab Emirates: Gulf Scientific Corporation (GSC), a leading provider of scientific and laboratory solutions, is pleased to announce a strategic partnership with GeneMind Biosciences, a pioneering developer of DNA sequencing systems. This alliance marks a significant milestone in our ongoing commitment to delivering innovative healthcare solutions and advancing molecular diagnostics. Founded with a focus on research and development, GeneMind Biosciences is a key player in the development of high-performance DNA sequencers - core instruments of modern molecular diagnostics. The company is committed to building a comprehensive precision medical ecosystem by collaborating with genetic testing service providers and medical institutions worldwide. This partnership with GSC represents a shared vision to enhance diagnostic capabilities, support cutting-edge scientific research, and ultimately improve patient outcomes. By combining GSC's extensive network and expertise with GeneMind's innovative sequencing technology, we aim to drive forward the future of healthcare through advanced molecular diagnostics, including non-invasive prenatal testing (NIPT). GSC is proud to represent GeneMind Biosciences in the UAE, Kuwait, Oman, Bahrain, and Qatar, bringing their groundbreaking NIPT technology to healthcare providers and patients across these markets. GeneMind's cutting-edge NIPT technology allows for early and accurate detection of fetal chromosomal abnormalities, reducing the risk of miscarriage and improving pregnancy outcomes. This technology has the potential to revolutionize prenatal care and improve the lives of expectant mothers. "We are excited to collaborate with GeneMind Biosciences, whose innovative DNA sequencing solutions align perfectly with our mission to empower healthcare providers to achieve their scientific objectives by providing innovative and reliable solutions, application support, and comprehensive after-sales services," stated Manaf Afyouni, Managing Director of Gulf Scientific Corporation. "Our partnership will enable us to bring cutting-edge NIPT technology to the region, enhancing prenatal care and improving patient outcomes." As part of this strategic partnership, GSC will be providing comprehensive support and services to healthcare professionals within the region. This collaboration will also facilitate the development of new research initiatives and projects focused on advancing molecular diagnostics and NIPT. We look forward to sharing updates on the groundbreaking initiatives and projects that will result from this strategic partnership. For more information about Gulf Scientific Corporation and our solutions, including GeneMind's NIPT technology, please visit Source: AETOSWire Contact details: Manaf Afyouni Email: marketing@ Website:
Web Release
2 days ago
- Web Release
Gulf Scientific Corporation announces strategic partnership with GeneMind Biosciences to advance molecular diagnostics and pioneer non-invasive prenatal testing (NIPT)
Gulf Scientific Corporation (GSC), a leading provider of scientific and laboratory solutions, is pleased to announce a strategic partnership with GeneMind Biosciences, a pioneering developer of DNA sequencing systems. This alliance marks a significant milestone in our ongoing commitment to delivering innovative healthcare solutions and advancing molecular diagnostics. Founded with a focus on research and development, GeneMind Biosciences is a key player in the development of high-performance DNA sequencers – core instruments of modern molecular diagnostics. The company is committed to building a comprehensive precision medical ecosystem by collaborating with genetic testing service providers and medical institutions worldwide. This partnership with GSC represents a shared vision to enhance diagnostic capabilities, support cutting-edge scientific research, and ultimately improve patient outcomes. By combining GSC's extensive network and expertise with GeneMind's innovative sequencing technology, we aim to drive forward the future of healthcare through advanced molecular diagnostics, including non-invasive prenatal testing (NIPT). GSC is proud to represent GeneMind Biosciences in the UAE, Kuwait, Oman, Bahrain, and Qatar, bringing their groundbreaking NIPT technology to healthcare providers and patients across these markets. GeneMind's cutting-edge NIPT technology allows for early and accurate detection of fetal chromosomal abnormalities, reducing the risk of miscarriage and improving pregnancy outcomes. This technology has the potential to revolutionize prenatal care and improve the lives of expectant mothers. 'We are excited to collaborate with GeneMind Biosciences, whose innovative DNA sequencing solutions align perfectly with our mission to empower healthcare providers to achieve their scientific objectives by providing innovative and reliable solutions, application support, and comprehensive after-sales services,' stated Manaf Afyouni, Managing Director of Gulf Scientific Corporation. 'Our partnership will enable us to bring cutting-edge NIPT technology to the region, enhancing prenatal care and improving patient outcomes.' As part of this strategic partnership, GSC will be providing comprehensive support and services to healthcare professionals within the region. This collaboration will also facilitate the development of new research initiatives and projects focused on advancing molecular diagnostics and NIPT. We look forward to sharing updates on the groundbreaking initiatives and projects that will result from this strategic partnership. For more information about Gulf Scientific Corporation and our solutions, including GeneMind's NIPT technology, please visit Source: AETOSWire
Zawya
29-04-2025
- Zawya
Orchid Fertility eliminates embryo biopsy risks with advanced genetic testing
Dubai, UAE – Orchid Fertility Dubai is at the forefront of reproductive technology with an innovative answer to one of the biggest challenges in assisted reproduction—i.e., the selection of the healthiest embryos while eliminating risks associated with traditional testing methods. With the introduction of Non-Invasive Preimplantation Genetic Testing (niPGT), Orchid Fertility is transforming the IVF experience to boost the likelihood of a successful pregnancy and minimize stress on embryos. Defective embryo genetics are among the primary causes of miscarriage, IVF failure, and birth defects. Technological advancements now offer new hope, though. Preimplantation Genetic Testing (PGT) allows doctors to screen embryos before implantation, so only the healthiest are selected., involves a biopsy—a process that extracts cells from the embryo to test which inevitably puts a small stress on the embryos. "Through the use of Non-Invasive Preimplantation Genetic Testing, we can analyze an embryo's genetic composition without the need for a biopsy," stated Dr. Dimitrios Kafetzis, Medical Director and Founding Doctor at Orchid Fertility Dubai. "This technology bypasses any risk, thereby allowing us to give our patients peace of mind and still provide information on their embryos" The niPGT method relies on the analysis of the DNA that the embryo naturally releases into the culture medium as it grows. This non-invasive approach enables specialists to screen for chromosomal abnormalities without compromising the structural integrity of the embryo. This technology is especially useful for women over 35 years of age, and those with multiple failed IVF cycles due to unexplained implantation failure. Orchid Fertility offers a complete set of genetic screening services, such as PGT-A for chromosome abnormalities like Down syndrome, PGT-M for monogenic conditions like sickle cell anemia and cystic fibrosis, PGT-SR for chromosomal translocations, and Carrier Screening for inherited disorders. "Selecting the most suitable embryo for implantation has long been an important aspect of in vitro fertilization; and we are always looking for a less invasive alternative to PGTA." NiPT is not a substitute of PGTA, but a screening tool to select the best embryos. Together with the latest generation embryoscope. Orchid Fertility is making best-in-class reproductive medicine accessible to families and thereby providing them with the greatest chance of having a healthy baby. About Orchid Fertility Orchid Fertility, part of Waha Health and located in the heart of Dubai Healthcare City, sets the benchmark for high-quality fertility care across the United Arab Emirates. The clinic is dedicated to providing evidence-based fertility treatments that meet international standards, offering couples the best possible chance of realizing their dream of having a healthy baby. With a holistic approach to fertility, Orchid Fertility emphasizes the importance of balancing the emotional, physical, and mental well-being of couples, recognizing that successful fertility treatment requires more than just medical intervention. The clinic's personalized care ensures that each couple's individual needs are met, including considerations of diet, stress management, and lifestyle improvements. Orchid Fertility is committed to enhancing the quality of life for couples seeking fertility assistance, with a focus on achieving healthy pregnancies and fostering the development of strong, healthy families. The clinic adheres to rigorous international quality standards, combining top-tier expertise with the latest advancements in technology, all while delivering compassionate and patient-centered care.
